Parenteral nutrition (PN) provides life-saving nutritional support in situations where caloric supply via the enteral route cannot cover the necessary needs of the organism. However, it does have serious adverse effects, including parenteral nutrition-associated liver disease (PNALD). The development of liver injury associated with PN is multifactorial, including non-specific intestine inflammation, compromised intestinal permeability, and barrier function associated with increased bacterial translocation, primary and secondary cholangitis, cholelithiasis, short bowel syndrome, disturbance of hepatobiliary circulation, lack of enteral nutrition, shortage of some nutrients (proteins, essential fatty acids, choline, glycine, taurine, carnitine, etc.), and toxicity of components within the nutrition mixture itself (glucose, phytosterols, manganese, aluminium, etc.). Recently, an increasing number of studies have provided evidence that some of these factors are directly or indirectly associated with microbial dysbiosis in the intestine. In this review, we focus on PN-induced changes in the taxonomic and functional composition of the microbiome. We also discuss immune cell and microbial crosstalk during parenteral nutrition, and the implications for the onset and progression of PNALD. Finally, we provide an overview of recent advances in the therapeutic utilisation of pro- and prebiotics for the mitigation of PN-associated liver complications.

Centre for Experimental Medicine Institute for Clinical and Experimental Medicine Department of Metabolism and Diabetes Videnska 1958 9 14021 Prague 4 Czech Republic

Centre of Diabetology Institute for Clinical and Experimental Medicine Department of Metabolism and Diabetes Videnska 1958 9 14021 Prague 4 Czech Republic

Zobrazit více v PubMed

Mizock B.A. Immunonutrition and critical illness: An update. Nutrition. 2010;26:701–707. doi: 10.1016/j.nut.2009.11.010. PubMed DOI

Beath S.V., Kelly D.A. Total Parenteral Nutrition-Induced Cholestasis: Prevention and Management. Clin. Liver Dis. 2016;20:159–176. doi: 10.1016/j.cld.2015.08.009. PubMed DOI

Drongowski R.A., Coran A.G. An analysis of factors contributing to the development of total parenteral nutrition-induced cholestasis. J. Parenter. Enter. Nutr. 1989;13:586–589. doi: 10.1177/0148607189013006586. PubMed DOI

Luman W., Shaffer J.L. Prevalence, outcome and associated factors of deranged liver function tests in patients on home parenteral nutrition. Clin. Nutr. 2002;21:337–343. doi: 10.1054/clnu.2002.0554. PubMed DOI

Bharadwaj S., Gohel T., Deen O.J., DeChicco R., Shatnawei A. Fish oil-based lipid emulsion: Current updates on a promising novel therapy for the management of parenteral nutrition-associated liver disease. Gastroenterol. Rep. 2015;3:110–114. doi: 10.1093/gastro/gov011. PubMed DOI PMC

Orso G., Mandato C., Veropalumbo C., Cecchi N., Garzi A., Vajro P. Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment. Dig. Liver Dis. 2016;48:215–222. doi: 10.1016/j.dld.2015.11.003. PubMed DOI

Mateu de Antonio J., Florit-Sureda M. Effects unrelated to anti-inflammation of lipid emulsions containing fish oil in parenteral nutrition for adult patients. Nutr. Hosp. 2017;34:193–203. doi: 10.20960/nh.882. PubMed DOI

Burcelin R., Serino M., Chabo C., Garidou L., Pomie C., Courtney M., Amar J., Bouloumié A. Metagenome and metabolism: The tissue microbiota hypothesis. Diabetes Obes. Metab. 2013;15:61–70. doi: 10.1111/dom.12157. PubMed DOI

Kverka M., Tlaskalova-Hogenova H. Intestinal Microbiota: Facts and Fiction. Dig. Dis. 2017;35:139–147. doi: 10.1159/000449095. PubMed DOI

Hodin C.M., Visschers R.G., Rensen S.S., Boonen B., Olde Damink S.W., Lenaerts K., Buurman W.A. Total parenteral nutrition induces a shift in the Firmicutes to Bacteroidetes ratio in association with Paneth cell activation in rats. J. Nutr. 2012;142:2141–2147. doi: 10.3945/jn.112.162388. PubMed DOI

Miyasaka E.A., Feng Y., Poroyko V., Falkowski N.R., Erb-Downward J., Gillilland M.G., Mason K.L., Huffnagle G.B., Teitelbaum D.H. Total parenteral nutrition-associated lamina propria inflammation in mice is mediated by a MyD88-dependent mechanism. J. Immunol. 2013;190:6607–6615. doi: 10.4049/jimmunol.1201746. PubMed DOI PMC

Heneghan A.F., Pierre J.F., Tandee K., Shanmuganayagam D., Wang X., Reed J.D., Steele J.L., Kudsk K.A. Parenteral nutrition decreases paneth cell function and intestinal bactericidal activity while increasing susceptibility to bacterial enteroinvasion. J. Parenter. Enter. Nutr. 2014;38:817–824. doi: 10.1177/0148607113497514. PubMed DOI PMC

Lapthorne S., Pereira-Fantini P.M., Fouhy F., Wilson G., Thomas S.L., Dellios N.L., Scurr M., O’Sullivan O., Ross R.P., Stanton C., et al. Gut microbial diversity is reduced and is associated with colonic inflammation in a piglet model of short bowel syndrome. Gut Microbes. 2013;4:212–221. doi: 10.4161/gmic.24372. PubMed DOI PMC

Harvey R.B., Andrews K., Droleskey R.E., Kansagra K.V., Stoll B., Burrin D.G., Sheffield C.L., Anderson R.C., Nisbet D.J. Qualitative and quantitative comparison of gut bacterial colonization in enterally and parenterally fed neonatal pigs. Curr. Issues Intest. Microbiol. 2006;7:61–64. PubMed

Deplancke B., Vidal O., Ganessunker D., Donovan S.M., Mackie R.I., Gaskins H.R. Selective growth of mucolytic bacteria including Clostridium perfringens in a neonatal piglet model of total parenteral nutrition. Am. J. Clin. Nutr. 2002;76:1117–1125. PubMed

Lavallee C.M., MacPherson J.A., Zhou M., Gao Y., Wizzard P.R., Wales P.W., Turner J.M., Willing B.P. Lipid Emulsion Formulation of Parenteral Nutrition Affects Intestinal Microbiota and Host Responses in Neonatal Piglets. J. Parent. Enteral. Nutr. 2016 doi: 10.1177/0148607116662972. PubMed DOI

Parm U., Metsvaht T., Ilmoja M.L., Lutsar I. Gut colonization by aerobic microorganisms is associated with route and type of nutrition in premature neonates. Nutr. Res. 2015;35:496–503. doi: 10.1016/j.nutres.2015.04.006. PubMed DOI

Ralls M.W., Miyasaka E., Teitelbaum D.H. Intestinal microbial diversity and perioperative complications. J. Parenter. Enter. Nutr. 2014;38:392–399. doi: 10.1177/0148607113486482. PubMed DOI PMC

Joly F., Mayeur C., Bruneau A., Noordine M.L., Meylheuc T., Langella P., Messing B., Duée P.H., Cherbuy C., Thomas M. Drastic changes in fecal and mucosa-associated microbiota in adult patients with short bowel syndrome. Biochimie. 2010;92:753–761. doi: 10.1016/j.biochi.2010.02.015. PubMed DOI

Dibaise J.K., Young R.J., Vanderhoof J.A. Enteric microbial flora, bacterial overgrowth, and short-bowel syndrome. Clin. Gastroenterol. Hepatol. 2006;4:11–20. doi: 10.1016/j.cgh.2005.10.020. PubMed DOI

Huang Y., Guo F., Li Y., Wang J., Li J. Fecal microbiota signatures of adult patients with different types of short bowel syndrome. J. Gastroenterol. Hepatol. 2017 doi: 10.1111/jgh.13806. PubMed DOI

Siggers R.H., Siggers J., Thymann T., Boye M., Sangild P.T. Nutritional modulation of the gut microbiota and immune system in preterm neonates susceptible to necrotizing enterocolitis. J. Nutr. Biochem. 2011;22:511–521. doi: 10.1016/j.jnutbio.2010.08.002. PubMed DOI

Wang S., Ng L.H., Chow W.L., Lee Y.K. Infant intestinal Enterococcus faecalis down-regulates inflammatory responses in human intestinal cell lines. World J. Gastroenterol. 2008;14:1067–1076. doi: 10.3748/wjg.14.1067. PubMed DOI PMC

Messing B., Lémann M., Landais P., Gouttebel M.C., Gérard-Boncompain M., Saudin F., Vangossum A., Beau P., Guédon C., Barnoud D., et al. Prognosis of patients with nonmalignant chronic intestinal failure receiving long-term home parenteral nutrition. Gastroenterology. 1995;108:1005–1010. doi: 10.1016/0016-5085(95)90196-5. PubMed DOI

Mayeur C., Gillard L., Le Beyec J., Bado A., Joly F., Thomas M. Extensive Intestinal Resection Triggers Behavioral Adaptation, Intestinal Remodeling and Microbiota Transition in Short Bowel Syndrome. Microorganisms. 2016;4:1. doi: 10.3390/microorganisms4010016. PubMed DOI PMC

Duncan S.H., Louis P., Thomson J.M., Flint H.J. The role of pH in determining the species composition of the human colonic microbiota. Environ. Microbiol. 2009;11:2112–2122. doi: 10.1111/j.1462-2920.2009.01931.x. PubMed DOI

Mayeur C., Gratadoux J.J., Bridonneau C., Chegdani F., Larroque B., Kapel N., Corcos O., Thomas M., Joly F. Faecal d/l lactate ratio is a metabolic signature of microbiota imbalance in patients with short bowel syndrome. PLoS ONE. 2013;8:e54335. doi: 10.1371/journal.pone.0054335. PubMed DOI PMC

Lilja H.E., Wefer H., Nystrom N., Finkel Y., Engstrand L. Intestinal dysbiosis in children with short bowel syndrome is associated with impaired outcome. Microbiome. 2015;3:18. doi: 10.1186/s40168-015-0084-7. PubMed DOI PMC

Belenguer A., Holtrop G., Duncan S.H., Anderson S.E., Calder A.G., Flint H.J., Lobley G.E. Rates of production and utilization of lactate by microbial communities from the human colon. FEMS Microbiol. Ecol. 2011;77:107–119. doi: 10.1111/j.1574-6941.2011.01086.x. PubMed DOI

Bourriaud C., Robins R.J., Martin L., Kozlowski F., Tenailleau E., Cherbut C., Michel C. Lactate is mainly fermented to butyrate by human intestinal microfloras but inter-individual variation is evident. J. Appl. Microbiol. 2005;99:201–212. doi: 10.1111/j.1365-2672.2005.02605.x. PubMed DOI

Sekirov I., Russell S.L., Antunes L.C., Finlay B.B. Gut microbiota in health and disease. Physiol. Rev. 2010;90:859–904. doi: 10.1152/physrev.00045.2009. PubMed DOI

Abreu M.T. Toll-like receptor signalling in the intestinal epithelium: How bacterial recognition shapes intestinal function. Nat. Rev. Immunol. 2010;10:131–144. doi: 10.1038/nri2707. PubMed DOI

Mazmanian S.K., Liu C.H., Tzianabos A.O., Kasper D.L. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell. 2005;122:107–118. doi: 10.1016/j.cell.2005.05.007. PubMed DOI

Christensen H.R., Frokiaer H., Pestka J.J. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J. Immunol. 2002;168:171–178. doi: 10.4049/jimmunol.168.1.171. PubMed DOI

Ivanov I.I., de Llanos Frutos R., Manel N., Yoshinaga K., Rifkin D.B., Sartor R.B., Finlay B.B., Littman D.R. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe. 2008;4:337–349. doi: 10.1016/j.chom.2008.09.009. PubMed DOI PMC

Beutler B., Rietschel E.T. Innate immune sensing and its roots: The story of endotoxin. Nat. Rev. Immunol. 2003;3:169. doi: 10.1038/nri1004. PubMed DOI

Kelsall B.L., Leon F. Involvement of intestinal dendritic cells in oral tolerance, immunity to pathogens, and inflammatory bowel disease. Immunol. Rev. 2005;206:132–148. doi: 10.1111/j.0105-2896.2005.00292.x. PubMed DOI

Kelly D., Campbell J.I., King T.P., Grant G., Jansson E.A., Coutts A.G., Pettersson S., Conway S. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat. Immunol. 2004;5:104. doi: 10.1038/ni1018. PubMed DOI

Lee J., Mo J.H., Katakura K., Alkalay I., Rucker A.N., Liu Y.T., Hyun-Ku L., Shen C., Cojocaru G., Shenouda S., et al. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat. Cell Biol. 2006;8:1327. doi: 10.1038/ncb1500. PubMed DOI

Iwasaki A., Kelsall B.L. Freshly isolated Peyer’s patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells. J. Exp. Med. 1999;190:229–239. doi: 10.1084/jem.190.2.229. PubMed DOI PMC

Macpherson A.J., Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science. 2004;303:1662–1665. doi: 10.1126/science.1091334. PubMed DOI

Peterson D.A., McNulty N.P., Guruge J.L., Gordon J.I. IgA response to symbiotic bacteria as a mediator of gut homeostasis. Cell Host Microbe. 2007;2:328–339. doi: 10.1016/j.chom.2007.09.013. PubMed DOI

Suzuki K., Meek B., Doi Y., Muramatsu M., Chiba T., Honjo T., Fagarasan S. Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut. Proc. Natl. Acad. Sci. USA. 2004;101:1981–1986. doi: 10.1073/pnas.0307317101. PubMed DOI PMC

Yanagibashi T., Hosono A., Oyama A., Tsuda M., Hachimura S., Takahashi Y., Itoh K., Hirayama K., Takahashi K., Kaminogawa S. Bacteroides induce higher IgA production than Lactobacillus by increasing activation-induced cytidine deaminase expression in B cells in murine Peyer’s patches. Biosci. Biotechnol. Biochem. 2009;73:372–377. doi: 10.1271/bbb.80612. PubMed DOI

Zipperer A., Konnerth M.C., Laux C., Berscheid A., Janek D., Weidenmaier C., Burian M., Schilling N.A., Slavetinsky C., Marschal M., et al. Human commensals producing a novel antibiotic impair pathogen colonization. Nature. 2016;535:511–516. doi: 10.1038/nature18634. PubMed DOI

Pierre J.F. Gastrointestinal immune and microbiome changes during parenteral nutrition. Am. J. Physiol. Gastrointest. Liver Physiol. 2017;312:G246–G256. doi: 10.1152/ajpgi.00321.2016. PubMed DOI PMC

Coulombe G., Langlois A., De Palma G., Langlois M.J., McCarville J.L., Gagné-Sanfaçon J., Perreault N., Feng G.S., Bercik P., Boudreau F., et al. SHP-2 Phosphatase Prevents Colonic Inflammation by Controlling Secretory Cell Differentiation and Maintaining Host-Microbiota Homeostasis. J. Cell. Physiol. 2016;231:2529–2540. doi: 10.1002/jcp.25407. PubMed DOI PMC

Everard A., Geurts L., Caesar R., van Hul M., Matamoros S., Duparc T., Denis R.G., Cochez P., Pierard F., Castel J., et al. Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status. Nat. Commun. 2014;5:5648. doi: 10.1038/ncomms6648. PubMed DOI PMC

Dheer R., Santaolalla R., Davies J.M., Lang J.K., Phillips M.C., Pastorini C., Vazquez-Pertejo M.T., Abreu M.T. Intestinal Epithelial Toll-Like Receptor 4 Signalling Affects Epithelial Function and Colonic Microbiota and Promotes a Risk for Transmissible Colitis. Infect. Immun. 2016;84:798–810. doi: 10.1128/IAI.01374-15. PubMed DOI PMC

Frantz A.L., Rogier E.W., Weber C.R., Shen L., Cohen D.A., Fenton L.A., Bruno M.E.C., Kaetzel C.S. Targeted deletion of MyD88 in intestinal epithelial cells results in compromised antibacterial immunity associated with downregulation of polymeric immunoglobulin receptor, mucin-2, and antibacterial peptides. Mucosal Immunol. 2012;5:501. doi: 10.1038/mi.2012.23. PubMed DOI PMC

Anitha M., Vijay-Kumar M., Sitaraman S.V., Gewirtz A.T., Srinivasan S. Gut microbial products regulate murine gastrointestinal motility via Toll-like receptor 4 signalling. Gastroenterology. 2012;143:1006–1016. doi: 10.1053/j.gastro.2012.06.034. PubMed DOI PMC

Cheesman S.E., Neal J.T., Mittge E., Seredick B.M., Guillemin K. Epithelial cell proliferation in the developing zebrafish intestine is regulated by the Wnt pathway and microbial signalling via Myd88. Proc. Natl. Acad. Sci. USA. 2011;108:4570–4577. doi: 10.1073/pnas.1000072107. PubMed DOI PMC

Cerovic V., Bain C.C., Mowat A.M., Milling S.W. Intestinal macrophages and dendritic cells: What’s the difference? Trends Immunol. 2014;35:270–277. doi: 10.1016/j.it.2014.04.003. PubMed DOI

Bain C.C., Bravo-Blas A., Scott C.L., Perdiguero E.G., Geissmann F., Henri S., Malissen B., Osborne L.C., Artis D., Mowat A.M. Constant replenishment from circulating monocytes maintains the macrophage pool in the intestine of adult mice. Nat. Immunol. 2014;15:929–937. doi: 10.1038/ni.2967. PubMed DOI PMC

Smith P.D., Smythies L.E., Shen R., Greenwell-Wild T., Gliozzi M., Wahl S.M. Intestinal macrophages and response to microbial encroachment. Mucosal Immunol. 2011;4:31–42. doi: 10.1038/mi.2010.66. PubMed DOI PMC

Denning T.L., Norris B.A., Medina-Contreras O., Manicassamy S., Geem D., Madan R., Karp C.L., Pulendran B. Functional specializations of intestinal dendritic cell and macrophage subsets that control Th17 and regulatory T cell responses are dependent on the T cell/APC ratio, source of mouse strain, and regional localization. J. Immunol. 2011;187:733–747. doi: 10.4049/jimmunol.1002701. PubMed DOI PMC

Rivollier A., He J., Kole A., Valatas V., Kelsall B.L. Inflammation switches the differentiation program of Ly6Chi monocytes from antiinflammatory macrophages to inflammatory dendritic cells in the colon. J. Exp. Med. 2012;209:139–155. doi: 10.1084/jem.20101387. PubMed DOI PMC

Schulz C., Perdiguero E.G., Chorro L., Szabo-Rogers H., Cagnard N., Kierdorf K., Prinz M., Wu B., Jacobsen S.E.W., Pollard J.W., et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science. 2012;336:86–90. doi: 10.1126/science.1219179. PubMed DOI

Hashimoto D., Chow A., Noizat C., Teo P., Beasley M.B., Leboeuf M., Becker C.D., See P., Price J., Lucas D., et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity. 2013;38:792–804. doi: 10.1016/j.immuni.2013.04.004. PubMed DOI PMC

Ueda Y., Kayama H., Jeon S.G., Kusu T., Isaka Y., Rakugi H., Yamamoto M., Takeda K. Commensal microbiota induce LPS hyporesponsiveness in colonic macrophages via the production of IL-10. Int. Immunol. 2010;22:953–962. doi: 10.1093/intimm/dxq449. PubMed DOI

Hayashi A., Sato T., Kamada N., Mikami Y., Matsuoka K., Hisamatsu T., Hibi T., Roers A., Yagita H., Ohteki T., et al. A single strain of Clostridium butyricum induces intestinal IL-10-producing macrophages to suppress acute experimental colitis in mice. Cell Host Microbe. 2013;13:711–722. doi: 10.1016/j.chom.2013.05.013. PubMed DOI

Ochi T., Feng Y., Kitamoto S., Nagao-Kitamoto H., Kuffa P., Atarashi K., Honda K., Teitelbaum D.H., Kamada N. Diet-dependent, microbiota-independent regulation of IL-10-producing lamina propria macrophages in the small intestine. Sci. Rep. 2016;6:27634. doi: 10.1038/srep27634. PubMed DOI PMC

Bevins C.L. Paneth cell defensins: key effector molecules of innate immunity. Biochem. Soc. Trans. 2006;34:263–266. doi: 10.1042/BST0340263. PubMed DOI

Porter E.M., Bevins C.L., Ghosh D., Ganz T. The multifaceted Paneth cell. Cell Mol. Life Sci. 2002;59:156–170. doi: 10.1007/s00018-002-8412-z. PubMed DOI PMC

Ouellette A.J. Defensin-mediated innate immunity in the small intestine. Best Pract. Res. Clin. Gastroenterol. 2004;18:405–419. doi: 10.1016/j.bpg.2003.10.010. PubMed DOI

Vaishnava S., Behrendt C.L., Ismail A.S., Eckmann L., Hooper L.V. Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc. Natl. Acad. Sci. USA. 2008;105:20858–20863. doi: 10.1073/pnas.0808723105. PubMed DOI PMC

Omata J., Pierre J.F., Heneghan A.F., Tsao F.H., Sano Y., Jonker M.A., Kudsk K.A. Parenteral nutrition suppresses the bactericidal response of the small intestine. Surgery. 2013;153:17–24. doi: 10.1016/j.surg.2012.04.001. PubMed DOI PMC

Kirkland D., Benson A., Mirpuri J., Pifer R., Hou B., DeFranco A.L., Yarovinsky F. B cell-intrinsic MyD88 signalling prevents the lethal dissemination of commensal bacteria during colonic damage. Immunity. 2012;36:228–238. doi: 10.1016/j.immuni.2011.11.019. PubMed DOI PMC

Teng F., Klinger C.N., Felix K.M., Bradley C.P., Wu E., Tran N.L., Umesaki Y., Wu H.J.J. Gut Microbiota Drive Autoimmune Arthritis by Promoting Differentiation and Migration of Peyer’s Patch T Follicular Helper Cells. Immunity. 2016;44:875–888. doi: 10.1016/j.immuni.2016.03.013. PubMed DOI PMC

Kim M., Qie Y., Park J., Kim C.H. Gut Microbial Metabolites Fuel Host Antibody Responses. Cell Host Microbe. 2016;20:202–214. doi: 10.1016/j.chom.2016.07.001. PubMed DOI PMC

Kudoh K., Shimizu J., Wada M., Takita T., Kanke Y., Innami S. Effect of indigestible saccharides on B lymphocyte response of intestinal mucosa and cecal fermentation in rats. J. Nutr. Sci. Vitaminol. 1998;44:103–112. doi: 10.3177/jnsv.44.103. PubMed DOI

Bjorkhem I. Mechanism of degradation of the steroid side chain in the formation of bile acids. J. Lipid Res. 1992;33:455–471. PubMed

Zhang Y., Limaye P.B., Renaud H.J., Klaassen C.D. Effect of various antibiotics on modulation of intestinal microbiota and bile acid profile in mice. Toxicol. Appl. Pharmacol. 2014;277:138–145. doi: 10.1016/j.taap.2014.03.009. PubMed DOI PMC

Chiang J.Y. Bile acid regulation of gene expression: Roles of nuclear hormone receptors. Endocr. Rev. 2002;23:443–463. doi: 10.1210/er.2000-0035. PubMed DOI

Fan M., Wang X., Xu G., Yan Q., Huang W. Bile acid signalling and liver regeneration. Biochim. Biophys. Acta. 2015;1849:196–200. doi: 10.1016/j.bbagrm.2014.05.021. PubMed DOI PMC

Duboc H., Tache Y., Hofmann A.F. The bile acid TGR5 membrane receptor: From basic research to clinical application. Dig. Liver Dis. 2014;46:302–312. doi: 10.1016/j.dld.2013.10.021. PubMed DOI PMC

Li T., Chiang J.Y. Bile acids as metabolic regulators. Curr. Opin. Gastroenterol. 2015;31:159–165. doi: 10.1097/MOG.0000000000000156. PubMed DOI PMC

Jones M.L., Martoni C.J., Ganopolsky J.G., Labbe A., Prakash S. The human microbiome and bile acid metabolism: Dysbiosis, dysmetabolism, disease and intervention. Expert Opin. Biol. Ther. 2014;14:467–482. doi: 10.1517/14712598.2014.880420. PubMed DOI

Ridlon J.M., Kang D.J., Hylemon P.B. Bile salt biotransformations by human intestinal bacteria. J. Lipid Res. 2006;47:241–259. doi: 10.1194/jlr.R500013-JLR200. PubMed DOI

Goodwin B., Jones S.A., Price R.R., Watson M.A., McKee D.D., Moore L.B., Galardi C., Wilson J.G., Lewis M.C., Roth M.E., et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol. Cell. 2000;6:517–526. doi: 10.1016/S1097-2765(00)00051-4. PubMed DOI

Holt M.P., Cheng L., Ju C. Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury. J. Leukoc. Biol. 2008;84:1410–1421. doi: 10.1189/jlb.0308173. PubMed DOI PMC

Miyata M., Takamatsu Y., Kuribayashi H., Yamazoe Y. Administration of ampicillin elevates hepatic primary bile acid synthesis through suppression of ileal fibroblast growth factor 15 expression. J. Pharmacol. Exp. Ther. 2009;331:1079–1085. doi: 10.1124/jpet.109.160093. PubMed DOI

Pereira-Fantini P.M., Lapthorne S., Joyce S.A., Dellios N.L., Wilson G., Fouhy F., Thomas S.L., Scurr M., Hill C., Gahan C.G., et al. Altered FXR signalling is associated with bile acid dysmetabolism in short bowel syndrome-associated liver disease. J. Hepatol. 2014;61:1115–1125. doi: 10.1016/j.jhep.2014.06.025. PubMed DOI

Nie Y.F., Hu J., Yan X.H. Cross-talk between bile acids and intestinal microbiota in host metabolism and health. J. Zhejiang Univ. Sci. B. 2015;16:436–446. doi: 10.1631/jzus.B1400327. (In Chinese) PubMed DOI PMC

Islam K.S., Fukiya S., Hagio M., Fujii N., Ishizuka S., Ooka T., Ogura Y., Hayashi T., Yokota A. Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. Gastroenterology. 2011;141:1773–1781. doi: 10.1053/j.gastro.2011.07.046. PubMed DOI

Cremers C.M., Knoefler D., Vitvitsky V., Banerjee R., Jakob U. Bile salts act as effective protein-unfolding agents and instigators of disulfide stress in vivo. Proc. Natl. Acad. Sci. USA. 2014;111:E1610–E1619. doi: 10.1073/pnas.1401941111. PubMed DOI PMC

Begley M., Gahan C.G., Hill C. The interaction between bacteria and bile. FEMS Microbiol. Rev. 2005;29:625–651. doi: 10.1016/j.femsre.2004.09.003. PubMed DOI

Inagaki T., Moschetta A., Lee Y.K., Peng L., Zhao G., Downes M., Ruth T.Y., Shelton J.M., Richardson J.A., Repa J.J., et al. Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc. Natl. Acad. Sci. USA. 2006;103:3920–3925. doi: 10.1073/pnas.0509592103. PubMed DOI PMC

D’Aldebert E., Mve M.J.B.B., Mergey M., Wendum D., Firrincieli D., Coilly A., Fouassier L., Corpechot C., Poupon R., Housset C., et al. Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors in the human biliary epithelium. Gastroenterology. 2009;136:1435–1443. doi: 10.1053/j.gastro.2008.12.040. PubMed DOI

Ohkohchi N., Andoh T., Izumi U., Igarashi Y., Ohi R. Disorder of bile acid metabolism in children with short bowel syndrome. J. Gastroenterol. 1997;32:472–479. doi: 10.1007/BF02934085. PubMed DOI

Pereira-Fantini P.M., Bines J.E., Lapthorne S., Fouhy F., Scurr M., Cotter P.D., Gahan C.G., Joyce S.A. Short bowel syndrome (SBS)-associated alterations within the gut-liver axis evolve early and persist long-term in the piglet model of short bowel syndrome. J. Gastroenterol. Hepatol. 2016;31:1946–1955. doi: 10.1111/jgh.13383. PubMed DOI

Sun X., Yang H., Nose K., Nose S., Haxhija E.Q., Koga H., Feng Y., Teitelbaum D.H. Decline in intestinal mucosal IL-10 expression and decreased intestinal barrier function in a mouse model of total parenteral nutrition. Am. J. Physiol. Gastrointest. Liver Physiol. 2008;294:G139–G147. doi: 10.1152/ajpgi.00386.2007. PubMed DOI

Deitch E.A. Gut-origin sepsis: Evolution of a concept. Surgeon. 2012;10:350–356. doi: 10.1016/j.surge.2012.03.003. PubMed DOI PMC

Alverdy J.C., Aoys E., Moss G.S. Total parenteral nutrition promotes bacterial translocation from the gut. Surgery. 1988;104:185–190. PubMed

Demehri F.R., Barrett M., Ralls M.W., Miyasaka E.A., Feng Y., Teitelbaum D.H. Intestinal epithelial cell apoptosis and loss of barrier function in the setting of altered microbiota with enteral nutrient deprivation. Front. Cell. Infect. Microbiol. 2013;3:105. doi: 10.3389/fcimb.2013.00105. PubMed DOI PMC

Feng Y., Sun X., Yang H., Teitelbaum D.H. Dissociation of E-cadherin and beta-catenin in a mouse model of total parenteral nutrition: A mechanism for the loss of epithelial cell proliferation and villus atrophy. J. Physiol. 2009;587:641–654. doi: 10.1113/jphysiol.2008.162719. PubMed DOI PMC

Wildhaber B.E., Yang H., Spencer A.U., Drongowski R.A., Teitelbaum D.H. Lack of enteral nutrition—Effects on the intestinal immune system. J. Surg. Res. 2005;123:8–16. doi: 10.1016/j.jss.2004.06.015. PubMed DOI

Demehri F.R., Barrett M., Teitelbaum D.H. Changes to the Intestinal Microbiome With Parenteral Nutrition: Review of a Murine Model and Potential Clinical Implications. Nutr. Clin. Pract. 2015;30:798–806. doi: 10.1177/0884533615609904. PubMed DOI

Feng Y., Teitelbaum D.H. Tumour necrosis factor—Induced loss of intestinal barrier function requires TNFR1 and TNFR2 signalling in a mouse model of total parenteral nutrition. J. Physiol. 2013;591:3709–3723. doi: 10.1113/jphysiol.2013.253518. PubMed DOI PMC

Yang H., Fan Y., Teitelbaum D.H. Intraepithelial lymphocyte-derived interferon-gamma evokes enterocyte apoptosis with parenteral nutrition in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2003;284:G629–G637. doi: 10.1152/ajpgi.00290.2002. PubMed DOI

Clayburgh D.R., Shen L., Turner J.R. A porous defense: The leaky epithelial barrier in intestinal disease. Lab. Investig. 2004;84:282–291. doi: 10.1038/labinvest.3700050. PubMed DOI

Yang H., Kiristioglu I., Fan Y., Forbush B., Bishop D.K., Antony P.A., Zhou H., Teitelbaum D.H. Interferon-gamma expression by intraepithelial lymphocytes results in a loss of epithelial barrier function in a mouse model of total parenteral nutrition. Ann. Surg. 2002;236:226–234. doi: 10.1097/00000658-200208000-00011. PubMed DOI PMC

Mitic L.L., Anderson J.M. Molecular architecture of tight junctions. Annu. Rev. Physiol. 1998;60:121–142. doi: 10.1146/annurev.physiol.60.1.121. PubMed DOI

Prasad S., Mingrino R., Kaukinen K., Hayes K.L., Powell R.M., MacDonald T.T., Collins J.E. Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells. Lab. Investig. 2005;85:1139–1162. doi: 10.1038/labinvest.3700316. PubMed DOI

Fanning A.S., Jameson B.J., Jesaitis L.A., Anderson J.M. The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J. Biol. Chem. 1998;273:29745–29753. doi: 10.1074/jbc.273.45.29745. PubMed DOI

Chen C., Wang P., Su Q., Wang S., Wang F. Myosin light chain kinase mediates intestinal barrier disruption following burn injury. PLoS ONE. 2012;7:e34946. doi: 10.1371/journal.pone.0034946. PubMed DOI PMC

Sinclair J.L., Alexander M. Role of resistance to starvation in bacterial survival in sewage and lake water. Appl. Environ. Microbiol. 1984;48:410–415. PubMed PMC

Costello E.K., Gordon J.I., Secor S.M., Knight R. Postprandial remodeling of the gut microbiota in Burmese pythons. ISME J. 2010;4:1375–1385. doi: 10.1038/ismej.2010.71. PubMed DOI PMC

Gionchetti P., Rizzello F., Helwig U., Venturi A., Lammers K.M., Brigidi P., Vitali B., Poggioli G., Miglioli M., Campieri M. Prophylaxis of pouchitis onset with probiotic therapy: A double-blind, placebo-controlled trial. Gastroenterology. 2003;124:1202–1209. doi: 10.1016/S0016-5085(03)00171-9. PubMed DOI

Mimura T., Rizzello F., Helwig U., Poggioli G., Schreiber S., Talbot I.C., Nicholls R.J., Gionchetti P., Campieri M., Kamm M.A. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut. 2004;53:108–114. PubMed PMC

Szajewska H., Ruszczynski M., Radzikowski A. Probiotics in the prevention of antibiotic-associated diarrhea in children: A meta-analysis of randomized controlled trials. J. Pediatr. 2006;149:367–372. doi: 10.1016/j.jpeds.2006.04.053. PubMed DOI

Barclay A.R., Stenson B., Simpson J.H., Weaver L.T., Wilson D.C. Probiotics for necrotizing enterocolitis: A systematic review. J. Pediatr. Gastroenterol. Nutr. 2007;45:569–576. doi: 10.1097/MPG.0b013e3181344694. PubMed DOI

Sentongo T.A., Cohran V., Korff S., Sullivan C., Iyer K., Zheng X. Intestinal permeability and effects of Lactobacillus rhamnosus therapy in children with short bowel syndrome. J. Pediatr. Gastroenterol. Nutr. 2008;46:41–47. doi: 10.1097/01.mpg.0000304452.92175.f5. PubMed DOI

Uchida K., Takahashi T., Inoue M., Morotomi M., Otake K., Nakazawa M., Tsukamoto Y., Miki C., Kusunoki M. Immunonutritional effects during synbiotics therapy in pediatric patients with short bowel syndrome. Pediatr. Surg. Int. 2007;23:243–248. doi: 10.1007/s00383-006-1866-6. PubMed DOI

Reddy V.S., Patole S.K., Rao S. Role of probiotics in short bowel syndrome in infants and children—A systematic review. Nutrients. 2013;5:679–699. doi: 10.3390/nu5030679. PubMed DOI PMC

Bartholome A.L., Albin D.M., Baker D.H., Holst J.J., Tappenden K.A. Supplementation of total parenteral nutrition with butyrate acutely increases structural aspects of intestinal adaptation after an 80% jejunoileal resection in neonatal piglets. J. Parenter. Enter. Nutr. 2004;28:210–222. doi: 10.1177/0148607104028004210. PubMed DOI

Murakoshi S., Fukatsu K., Omata J., Moriya T., Noguchi M., Saitoh D., Koyama I. Effects of adding butyric acid to PN on gut-associated lymphoid tissue and mucosal immunoglobulin A levels. J. Parenter. Enter. Nutr. 2011;35:465–472. doi: 10.1177/0148607110387610. PubMed DOI

Rolandelli R.H., Buckmire M.A., Bernstein K.A. Intravenous butyrate and healing of colonic anastomoses in the rat. Dis. Colon Rectum. 1997;40:67–70. doi: 10.1007/BF02055684. PubMed DOI

Stein T.P., Yoshida S., Schluter M.D., Drews D., Assimon S.A., Leskiw M.J. Comparison of intravenous nutrients on gut mucosal proteins synthesis. J. Parenter. Enter. Nutr. 1994;18:447–452. doi: 10.1177/0148607194018005447. PubMed DOI

Koruda M.J., Rolandelli R.H., Bliss D.Z., Hastings J., Rombeau J.L., Settle R.G. Parenteral nutrition supplemented with short-chain fatty acids: Effect on the small-bowel mucosa in normal rats. Am. J. Clin. Nutr. 1990;51:685–689. PubMed

Wang P., Wang Y., Lu L., Yan W., Tao Y., Zhou K., Jie J., Wei C. Alterations in intestinal microbiota relate to intestinal failure-associated liver disease and central line infections. J. Pediatr. Surg. 2017;52:1318–1326. doi: 10.1016/j.jpedsurg.2017.04.020. PubMed DOI

De Minicis S., Rychlicki C., Agostinelli L., Saccomanno S., Candelaresi C., Trozzi L., Mingarelli E., Facinelli B., Magi G., Palmieri C., et al. Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice. Hepatology. 2014;59:1738–1749. doi: 10.1002/hep.26695. PubMed DOI

El Kasmi K.C., Anderson A.L., Devereaux M.W., Fillon S.A., Harris J.K., Lovell M.A., Finegold M.J., Sokol R.J. Toll-like receptor 4-dependent Kupffer cell activation and liver injury in a novel mouse model of parenteral nutrition and intestinal injury. Hepatology. 2012;55:1518–1528. doi: 10.1002/hep.25500. PubMed DOI PMC

Harris J.K., El Kasmi K.C., Anderson A.L., Devereaux M.W., Fillon S.A., Robertson C.E., Wagner B.D., Stevens M.J., Pace N.R., Sokol R.J. Specific microbiome changes in a mouse model of parenteral nutrition associated liver injury and intestinal inflammation. PLoS ONE. 2014;9:e110396. doi: 10.1371/journal.pone.0110396. PubMed DOI PMC

Lee W.S., Sokol R.J. Intestinal Microbiota, Lipids, and the Pathogenesis of Intestinal Failure-Associated Liver Disease. J. Pediatr. 2015;167:519–526. doi: 10.1016/j.jpeds.2015.05.048. PubMed DOI PMC

The effect of ω-3 polyunsaturated fatty acids on the liver lipidome, proteome and bile acid profile: parenteral versus enteral administration